NCT05692505View on ClinicalTrials.gov

Multicenter Performance Study of QuadQuik Invitro Diagnostic Device

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 1, 2023

Study Completion Date

June 1, 2023

Conditions
HIV InfectionsHepatitis CHepatitis BSyphilis Infection
Interventions
DIAGNOSTIC_TEST

QuadQuik

Invitro diagnostic device

Trial Locations (1)

92121

Genlantis Diagnostics, San Diego

Sponsors
All Listed Sponsors
collaborator

Ahsan Awan

UNKNOWN

lead

Genlantis Diagnostics

INDUSTRY